Business
Economy
Investing
Politics

Top Posts

Stocks have their worst quarter since 2022, raising...

Hershey to resume using chocolate in most products;...

Republican leaders announce two-track plan to end the...

Body found in Colombia amid search for missing...

Trump says his ‘preference’ would be to ‘take...

U.S. crude tops $100 and the S&P 500...

The world economy is experiencing the most severe...

Average U.S. gas price hits $4 for the...

A global jet fuel shortage is raising the...

House Republicans pass DHS funding bill that Democrats...

Business
Economy
Investing
Politics

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

next post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

RAD Increases Ownership in Radiopharm Ventures to 75%

August 26, 2024

Potash Fertilizers: What’s the Difference Between SOP and...

January 24, 2025

Altech Batteries LtdDesign Completed for UPS Battery System

November 27, 2025

Silver North Provides Tim Drilling Progress Update

August 20, 2024

Tech Weekly: Chip Stocks Soar on Taiwan Semiconductor...

January 17, 2026

Hydrogen Stocks: 9 Biggest Companies

March 21, 2025

Pilbara Gold Exploration Update and Planned Activities –...

January 30, 2025

John Rubino: Gold on “Epic Run” as Chaos...

May 3, 2025

Spearmint More Than Doubles the Acreage of the...

December 14, 2024

Editor’s Picks: Gold Price Recovers from Biggest One-Day...

October 25, 2025

Fill Out & Get More Relevant News

Your name
Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

Recent Posts

Stocks have their worst quarter since 2022, raising doubts about Trump’s economic playbook
April 3, 2026
Hershey to resume using chocolate in most products; Reese’s grandson may taste sweet victory
April 3, 2026
Republican leaders announce two-track plan to end the DHS shutdown
April 3, 2026
Body found in Colombia amid search for missing U.S. flight attendant
April 2, 2026
Trump says his ‘preference’ would be to ‘take the oil in Iran’
April 2, 2026

banner ads

Categories

Business (974)
Economy (839)
Investing (4,085)
Politics (747)

Privacy Policy
Terms & Conditions

Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2026 smarttradeinsights.com | All Rights Reserved